Trials / Recruiting
RecruitingNCT05939310
Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study
Improving Radical Resection Rates in Patients With Breast Cancer by Intraoperative Imaging Using Bevacizumab-IRDye800CW - the MARGIN-2 Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to intraoperatively visualize tumour tissue in breast cancer patients using fluorescence imaging with the tracer bevacizumab-IRDye800CW and thereby enhance real-time clinical decision making, preventing postoperative tumour-positive margins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fluorescence guided detection of tumor positive margins. | Intraoperative fluorescence imaging detection of tumor positive margins using the targeted tracer bevacizumab-IRDye800CW. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-09-30
- Completion
- 2024-12-30
- First posted
- 2023-07-11
- Last updated
- 2024-04-19
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05939310. Inclusion in this directory is not an endorsement.